Sanzyme Biologics Pvt Ltd is a prominent entity within the biopharmaceutical industry, recognised for its contributions to the fields of Contract Manufacturing (CMO/CDMO) and Generics/Biosimilars. Established as India’s first Indo-Japanese pharmaceutical joint venture, Sanzyme focuses on the manufacturing of infertility hormones, specifically gonadotropins, and probiotics. The company boasts an EU-approved gonadotropin facility that is poised to enter the European market, supported by a ready eCTD dossier. With a presence in over 35 countries, Sanzyme Biologics is strategically expanding its global footprint, leveraging its extensive 50 years of fermentation experience to provide innovative solutions in the biopharmaceutical realm.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Manufacturing of infertility hormones (gonadotropins)
– Production of probiotics
– Contract development and manufacturing (CDMO) services for microbial recombinant proteins
– Development and manufacturing services for fermentation-derived ingredients

With a commitment to excellence and innovation, Sanzyme Biologics Pvt Ltd continues to be a reliable partner in the pharmaceutical industry. For more information, please visit sanzyme.com.